|Brand||Healing Pharma India Pvt Ltd|
|Packaging Size||21 tabs|
Desogestrel 0.15 mg + Ethinyl Estradiol 0.03 mg (Noveheal) 0.15/ 0.03 mg tablet is a combined medicine used as an oral contraceptive (birth control pill). It is used to prevent pregnancy.
Drug = Desogestrel 0.15mg + Ethinyl Estradiol 0.03mg
Number of Pills Per Order = 21
Strength = 0.15/ 0.03 mg
Manufacturer = Healing Pharma
How To Take
Take Desogestrel+Ethinylestradiol precisely as directed by your doctor or according to the instructions on the label. Do not take more or less than instructed by your doctor.
Try to take it at the same time each day.
Adult: Dosing instruction may vary according to the brand. For 21-day pack: Start on 1st day of menses. One tab/day for 21 days, followed by seven pill-free days. Start a new box on the 8th day after the last tab is taken. For 28-day pack: Start on 1st day of menses. One tab/day without interruption. Take the dose at the same time every day.
If you miss a dose, skip the missed dose and return to your regular dosing schedule. If you often forget to take your medicine, let your doctor and pharmacist know.
Do not double a dose under any circumstances.
Signs of overdose may include the following:
- Treatment is symptomatic.
Seek medical help immediately.
People with the following medical conditions should not take Desogestrel+Ethinylestradiol:
- History of or current thrombophlebitis or venous thromboembolic disorders
- Active or recent (within 1 year) arterial thromboembolic disease, e.g., stroke
- Heart attack
- Cerebrovascular disease
- Coronary artery disease
- Valvular heart disease with complications
- Severe hypertension
- Diabetes mellituswith vascular involvement
- Severe headache with focal neurological symptoms
- Known or suspected breast carcinoma
- Endometrial cancer
- Estrogen-dependent neoplasms
- Undiagnosed abnormal genital bleeding
- Hepatic dysfunction or tumor
- Cholestatic jaundice of pregnancy
- Jaundice with prior combined hormonal contraceptive use
- Major surgery with prolonged immobilization
Desogestrel+Ethinylestradiol may have the following side effects:
- Intermenstrual bleeding
- Post-medication amenorrhoea
- Changes in cervical secretion
- Increase in size of uterine fibromyomata
- Aggravation of endometriosis and certain vaginal infections
- Breast tenderness
- Enlargement or secretion
- Cholestatic jaundice
- Mood changes
- Fluid retention
- Change in body weight
- Reduced glucose tolerance
Do not use Desogestrel + ethinylestradiol in people with the following conditions:
- History or currently have blood clot disorder
- Heart attack
- Severe or uncontrolled high blood pressure
- Abnormal levels of cholesterol and fats in the blood
- Liver cancer
- Sex-hormone sensitive cancers
- Undiagnosed vaginal bleeding
- Inflammation of the pancreas
- Have significant surgery which may cause a limited ability to move around
- Increased age (>35 years old)
- Family history of blood clot disorder
- Systemic lupus erythematosus
- Gallbladder disease
- Inflammation of the bowels
- History of chloasma
- Hereditary angioedema
Keep your appointments with your doctor. Your doctor needs to monitor your condition and check your response to the medication regularly.
How Does It Work?
Desogestrel + Ethinylestradiol is used together to inhibit ovulation by a negative feedback mechanism on the hypothalamus, which alters the normal FSH and LH secretion pattern by the anterior pituitary. It also causes changes in the cervical mucus, making it unsuitable for sperm penetration.
Desogestrel+Ethinylestradiol is used to treat the following conditions:
- As an oral contraceptive to prevent pregnancy
Special Precautions and Connected Warnings
Take special precautions if you have the following conditions:
- Breast cancer
- Glucose intolerance
- May affect serum levels of triglyceride and lipoprotein
- Caution when used in patients with familial defects of lipoprotein metabolism
- Discontinue treatment if papilledema or retinal vascular lesions are observed on eye examination
- Patients with risk factors for coronary artery disease
- Patients with depression or history of migraine
- Renal impairment
- Increased cardiovascular risk in smoking women especially those >35 years
- Treatment should be stopped for 4weeks before and for 2 weeks after surgery associated with increased risk of thromboembolism or during periods of prolonged immobilization
- Avoid alcohol and grapefruit juice
- Store in a cool, dry place away from the reach of children.
- Do not use Desogestrel + ethinylestradiol that is expired or out of date.